Radiopharmaceutics (4) Flashcards

1
Q

Why isn’t it as straightforward as paracetamol

A
  • Most radiopharmaceuticals do not have a pharmacological effect
  • chemically small quantities- difficult to study, little in-vitro testing
  • Relies on reporting- numbers small
    • Lots of evidence anecdotal
    • Difficult to establish cause and effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Some interactions are useful

A
  • Diuretics
  • Vasodilators
  • Expected interactions are not a problem
  • BUT- What about the unexpected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of interaction

A
  • Classified by C.Sampson
    • Patient medication as a possible cause of unexpected biodistribution of radiopharmaceutcial; a regional survey
    • Drugs and chemicals which affect the purity, biodistribution and PK of radiopharmaceuticals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Categories

A
  1. Unusual handling of the radiopharmaceutical as a result pharmacological effect
  2. In-vivo physicochemical interaction between radiopharmaceutical and patients medication
  3. Drug-induced disease affecting the transport of radiopharmaceuticals
  4. Drugs which interfere with the radiolabelling of white cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

1) Unusual handling of the radiopharmaceutical as a result of pharmacological effect

Definition

A
  • A pharmacological interaction occurs when the intended effect of a drug at it’s usual dose alters the biodistribution of the radiopharmaceutical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Direct pharmaceutical effect

A
  • The pharmacological effect of a drug causes the organ to function differently
  • Largest group-most reports
  • Effect predicted and expected from the mode of action of the drug i.e. class effect
    • These have usually been previously reported
  • Effect unexpected- not class related ‘Drug effect’
  • It is important to determine if drug effects are drug specific or class specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Example 1: Hepatobiliary studies

A
  • Hepatobiliary function is investigated using 99mTc labelled compounds of imnodiacetic acid (IDA) e.g. mebrofenin
  • This is cleared from the circulation by the hepatic cells and secreted like bilirubin into the bile carrier mechanism
  • Various conditions may delay movement of the radiopharmaceutical through the hepatobiliary system resulting in delayed gallbladder visualisation- prolonged tasting, TPN, Viscous bile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drugs which interact with hepatobiliary imaging agents

A
  • Opioid analgesic- cause constriction of the sphincter of Oddi increasing pressure in the common bile duct; could increase transit time of RP (radiopharmaceutical)
    • Class specific
  • Enzyme inducer- Phenobarbitone enhance and accelerate biliary excretion of RP increasing accurate differentiation between extrahepatic biliary atresia and neonatal hepatitis
    • Class specific
  • Anaesthetic -Halothane showed to cause a marked decrease in hepatic blood flow, reduced uptake of RP in liver
    • Drug-specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Example 2: Effect of cytotoxic drugs

A
  • Cytotoxic drugs + 99m-Tc PYP (Blood pool imaging)
  • Intense renal uptake was reported (Lutrin et al 1978)
  • Suggested that it was due to altered renal tubular function or reduced GFR
    • Class specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Example 3: Thyroid imaging

A
  • Any drug which interferes with the uptake of iodine, or blocks it’s release from the thyroid can interfere with the uptake of tracer and lead to misdiagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs which can affect thyroid imaging with 123-I

A
  • Thyroxine
  • Amiodarone
  • Iodine containing contrast media
  • Vitamin preparations
  • Anti-histamines
  • Steroids
  • Seafood containging high levels of iodine
  • Iodine based cough medicine
  • Hair dye
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drugs which can affect thyroid therapy with 131-I or imaging with 123-I

A
  • Hyperthyroidism: Carbimazole and Propylthiouracil interfere with the organification of iodine so would prevent the therapeutic effect of radioiodine
  • Withdraw 1 week before therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drugs which can affect thyroid imaging with 123-I

A
  • Hypothyroidism
    • Biological t1/2 of thyroxine (T4)-7 days- ideally 1 month due to residual
    • Biological t1/2 of liothyronine (T3) 2 days
  • Therefore stop T4 28 days before test, use T3 for 14 days then stop 14 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Example 4: Heart investigations with 99m-Tc- Tetrofosmin/Adenosine

A
  • The following drugs could lead to false negative results
    • Beta-blockers may blunt the response to exercise-induced stress- should be stopped for 5 half-lives 24-48hrs
    • Calcium channel blockers- Diltiazem and verapamil
    • Dipyridamole- blocks uptake of Adenosine- we use adenosine due to its small half-life- any side effects will not last very long
    • Patients also instructed to abstain from caffeine for 12 hours tea, coffee and soft drinks such as cola, energy drinks (blocks Adenosine receptor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Example 5: drugs which affect the monoamine transporter uptake mechanism

There are several different Monoamine transporters

A
  1. The Norepinephrine transport NET
  2. The Dopamine transporter DAT
  3. The serotonin transporter SERT
  • A mixture of drug and class-specific interaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nerve synapse

A

*

17
Q

Example: MIBG (metoiodo-benzyl-guanidine)

Norepinephrine transporter NET

A
  • mIBG is meta-iodobenzylguanidine
  • Catecolamine analogue- attaches to receptors in body
  • May interact with anything which affects receptor- e.g. Beta-blockers and agonists, reserpine, some antidepressents
  • Used for tumours of adrenal medulla
18
Q

5 mechanisms of interaction

A
  1. Inhibition of sodium-dependent uptake system- The NET transporter e.g. TCA’s, cocaine, labetalol
  2. Inhibition of uptake by active transport into vesicles- i.e. inhibition of granular uptake within the terminal e.g. reserpine
  3. Competition for transport into vesicles e.g. serotonin
  4. Depletion of content from storage vesicles
    • e.g. labetalol, reserpine
  5. Calcium channel-mediated inhibition
    • Calcium channel blockers
19
Q

Other possible unknown mechanism

A
  • Effect of dose: phenoxybenzamine at high dose may reduce or prevent MIBG uptake
  • This does not happen at normal doses
20
Q

Post-synaptic neurone

A
21
Q

Prior to MIBG

A
  • Radiopharmacist prepares a list of interacting drugs, updated regularly
    • Resperpine (no longer used in UK)
    • TCA
    • Sympathomimetics
    • Neuroleptics
    • Labetalol
    • IV-Phenoxybenzamine
    • Calcium channel blockers
    • Amiodarone- difficulty of long t1/2
22
Q

123-I Ioflupane (DaTSCAN)

The Dopamine Transporter DAT

A
  • Ioflupane is a cocaine analogue
  • Drug which bind to the dopamine transporter with high affinity can affect studies
  • Dopamine agonist/antagonists acting on post synatpic recpeotrs do not interfere
23
Q

Drugs which should be stopped prior to DaTSCAN

A
  • Radiopharmacist prepares a list of interacting drugs
  • CNS stimulants- dexamfetamine, methylphenidate and modafinil
    • Anti-depressant- Amoxapine
    • Anxiolytic- Buspirone
    • Amfebutamone (Bupropion)
    • Sibutramine
    • Pimozide
    • Benzatropine
    • SSRI- very weak DAT inhibitor
    • Cocaine
24
Q

Stopping medication prior to mIBG and DaTSCAN: process

A
  • Medication history took when arranging mIBG or DaTSCAN
  • Stop interacting drugs for 5 biological half-lives
  • Clinicians must be consulted- particularly important for antihypertensive and neuroleptics
25
Q

2) In-vivo physicochemical interaction between radiopharmaceutical and patients medication

A
  • These are as a result of a genuine reaction between a drug and radiopharmaceutical
  • Little is known about the mechanism of action of these interactions at the molecular level- possibly the formation of local complexes alters biodistribution
26
Q

IM Iron Dextran and MDP

A
  • MDP is chelated, producing an insoluble complex
  • Instead of localising throughout the skeleton activity is observed in the gluteal region at site of iron injection
  • Thought that local complexation reaction between reduced Tc and ferric hydroxide occurs
27
Q

Bisphosphonates and MDP

A
  • Bisphosphonates used for Paget’s cause reduced skeletal uptake of TC diphosphonates
  • Tc can form preferential complexes with circulating Bisphosphonates, and so the amount taken up into the skeleton is reduced
28
Q

Aluminium and colloids

A
  • Aluminium- containing drugs (e.g. antacids) colloidal radiopharmaceuticals preparations
  • Aluminium causes colloid particles to flocculate together
  • Distribution of the colloid can effect radiopharmaceuticals
29
Q

3) Drug-induced disease affecting the transport of radiopharmaceuticals

A
  • This occurs when an extension of the expected pharmacological effect or an adverse reaction to a drug alters the biodistribution of the RP
  • Many drugs can cause or aggravate disease iatrogenic disease
  • Example- 1
    • Drug-induced liver damage could cause altered liver uptake of radiopharmaceuticals
30
Q

Hepatotoxic drugs

A
  • Paracetamol, aspirin, tetracycline- reduce liver uptake
  • TPN theapy- cause fatty liver disease
  • Erythromycin- false +ve scan with T-BIDA
  • MTX- diffuse accumulation of MDP in liver
31
Q

Example-2

A
  • Drug-induced renal toxicity will affect behaviour of renal imaging agnets or of agents which are renally excreted
  • Nephrotoxic drugs
    • Many drugs can cause nephrotoxicity and decrease in GFR
      • Aminoglycosides, penicillins, cytotoxics, amphotericin, cyclosporin
    • Conversely diuretics e.g. furosemide can improve renal function
32
Q

Example 3: Pulmonary toxicity

A
  • The most common drug is bleomycin which can cause pulmonary interstitial fibrosis- this can cause high lung uptake of 67-Gallium citrate
  • Other drugs which may cause abnormal lung uptake- amiodarone, busulphan and nitrofurantoin
33
Q

Other factors which may cause unusual handling of RP

A
  • Radiation therapy
  • Diet
  • Degree of hydration- renal studies
  • Caffeine intake
  • Fasting status- affects absorption and motility in the gut
  • Alcohol
34
Q

4) Drugs which interfere with the radiolabelling of white cells

A
  • Many factors can influence the radiolabelling of blood cells- e.g. white cell count, volume, temperature
  • Increasingly there is evidence to suggest that drug treatment may also interfere
35
Q

Example

A
  • Chemotaxis of leucocytes may be affected by
    • Anti-biotics
    • Corticosteroids
  • In study 7 out of 15 patients reported to have unusually low labelling efficiencies were on corticosteroids
36
Q

Drugs which interfere with leucocyte labelling

A
37
Q

Conclusion

A
  • Patient drug therapy can interfere with radiopharmaceutical uptake and distribution
  • Much of the evidence is anecdotal and the mechanisms unclear
  • Knowing the important and likely interactions can help prevent repeat radiation doses, and in some events, incorrect diagnosis